Marathon Partners Equity Management’s Interxion Holding N.V. INXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-55,000
Closed -$2.98M 20
2018
Q4
$2.98M Sell
55,000
-7,500
-12% -$450K 1.4% 16
2018
Q3
$4.21M Sell
62,500
-27,500
-31% -$1.78M 1.63% 13
2018
Q2
$5.62M Hold
90,000
1.96% 12
2018
Q1
$5.59M Sell
90,000
-52,500
-37% -$3.13M 2.07% 12
2017
Q4
$8.4M Hold
142,500
3.38% 10
2017
Q3
$7.26M Hold
142,500
3.19% 12
2017
Q2
$6.52M Sell
142,500
-62,500
-30% -$2.7M 2.99% 15
2017
Q1
$8.11M Hold
205,000
3.83% 10
2016
Q4
$7.19M Hold
205,000
3.05% 15
2016
Q3
$7.42M Sell
205,000
-50,000
-20% -$1.87M 3.67% 7
2016
Q2
$9.4M Sell
255,000
-185,000
-42% -$6.56M 3.97% 6
2016
Q1
$15.2M Buy
440,000
+5,000
+1% +$156K 6.36% 3
2015
Q4
$13.1M Hold
435,000
5.5% 4
2015
Q3
$11.8M Buy
435,000
+260,000
+149% +$7.2M 5.09% 5
2015
Q2
$4.84M Buy
+175,000
New +$5.19M 1.96% 10

Other funds holding INXN

Marathon Partners Equity Management's INXN Position: Q1 2019 in Review

Marathon Partners Equity Management sold out of Interxion Holding N.V. (INXN) in Q1 2019, closing a stake of 55,000 shares — an estimated $2.98M sold.

Marathon Partners Equity Management first reported a position in INXN in Q2 2015 and held it in 15 quarters. The position peaked at $15.2M in Q1 2016. 231 funds tracked by Wall St. Rank hold INXN as of Q1 2019.

  • Marathon Partners Equity Management reported no remaining Interxion Holding N.V. position as of Q1 2019 after selling out during the quarter.
  • Marathon Partners Equity Management sold 55,000 Interxion Holding N.V. shares in Q1 2019, an estimated $2.98M.
  • Marathon Partners Equity Management first reported a position in Interxion Holding N.V. in Q2 2015 and held it in 15 quarters.
  • Marathon Partners Equity Management's Interxion Holding N.V. position peaked at $15.2M in Q1 2016.
  • 231 funds tracked by Wall St. Rank held Interxion Holding N.V. as of Q1 2019.

Based on Marathon Partners Equity Management's 13F filing for Q1 2019, filed 15 May 2019.